SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Carter JD, Hudson AP. Reactive arthritis: clinical aspects and medical management. Rheum Dis Clin North Am 2009; 35: 2144.
  • 2
    Carter JD, Espinoza LR, Inman RD, Sneed KB, Ricca LR, Vasey FB, et al. Combination antibiotics as a treatment for chronic Chlamydia-induced reactive arthritis: a double-blind, placebo-controlled, prospective trial. Arthritis Rheum 2010; 62: 1298307.
  • 3
    Kuipers JG, Zeidler H, Kohler L. How does Chlamydia cause arthritis? Rheum Dis Clin North Am 2003; 29: 61329.
  • 4
    Bas S, Neff L, Vuillet M, Spenato U, Seya T, Gabay C, et al. The proinflammatory cytokine response to Chlamydia trachomatis elementary bodies in human macrophages is partly mediated by a lipoprotein, the macrophage infectivity potentiator, through TLR2/TLR1/TLR6 and CD14. J Immunol 2008; 180: 115868.
  • 5
    Gaston JS, Deane KH, Jecock RM, Pearce JH. Identification of 2 Chlamydia trachomatis antigens recognized by synovial fluid T cells from patients with Chlamydia induced reactive arthritis. J Rheumatol 1996; 23: 1306.
  • 6
    Butrimiene I, Jarmalaite S, Ranceva J, Venalis A, Jasiuleviciute L, Zvirbliene A. Different cytokine profiles in patients with chronic and acute reactive arthritis. Rheumatology (Oxford) 2004; 43: 13004.
  • 7
    Singh R, Aggarwal A, Misra R. Th1/Th17 cytokine profiles in patients with reactive arthritis/undifferentiated spondylarthropathy. J Rheumatol 2007; 34: 228590.
  • 8
    Kingsley G, Sieper J. Third international workshop on reactive arthritis. 23-26 September 1995, Berlin, Germany. Ann Rheum Dis 1996; 55: 56470.
  • 9
    Pacheco-Tena C, Burgos-Vargas R, Vazquez-Mellado J, Sazarin J, Perez-Diaz JA. A proposal for classification of patients for clinical and experimental studies on reactive arthritis. J Rheumatol 1999; 26: 133846.
  • 10
    Flagg SD, Meador R, Hsia E, Kitumnuaypong T, Schumacher HR Jr. Decreased pain and synovial inflammation after etanercept therapy in patients with reactive and undifferentiated arthritis: an open-label trial. Arthritis Rheum 2005; 53: 6137.
  • 11
    Kaipiainen-Seppanen O, Niinisalo H, Korpilahde T, Virolainen J. Treatment of reactive arthritis with infliximab. Scand J Rheumatol 2003; 32: 1224.
  • 12
    Gaylis N. Infliximab in the treatment of an HIV positive patient with Reiter's syndrome. J Rheumatol 2003; 12: 1097109.
  • 13
    Gill H, Majithia V. Successful use of infliximab in the treatment of Reiter's syndrome: a case report and discussion. Clin Rheumatol 2008; 27: 1213.
  • 14
    Schafranski MD. Infliximab for reactive arthritis secondary to Chlamydia trachomatis infection. Rheumatol Int 2010; 30: 67980.
  • 15
    Abdelmoula LC, Yahia CB, Testouri N, Tekaya R, Ben M'barek R, Chaabouni L, et al. Treatment of reactive arthritis with infliximab. Tunis Med 2008; 86: 10957. In French.